Patent directory · USPTO A61K / A61P
Patents matching “TEVA PHARMACEUTICALS AUSTRALIA PTY LTD”
15 pharma patents match "TEVA PHARMACEUTICALS AUSTRALIA PTY LTD" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 15 pharmaceutical patents matching "TEVA PHARMACEUTICALS AUSTRALIA PTY LTD" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12258401
Anti-CD47 combination therapy
granted -
US 11618784
Anti-CD47 combination therapy
granted -
US 11319356
Interferon alpha 2B variants
granted -
US 11253591
Combination of lenalidomide and polypeptide construct, and uses thereof
granted -
US 11117975
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
granted -
US 10981986
Fusions of antibodies to CD38 and attenuated interferon alpha
granted -
US 10822422
Antibodies against TL1a and uses thereof
granted -
US 10544199
Interferon alpha 2B variants
granted -
US 9963515
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
granted -
US 9636334
Combination of lenalidomide and polypeptide construct, and uses thereof
granted -
US 9611322
Fusions of antibodies to CD38 and attenuated interferon alpha
granted -
US 9505826
Modified antibody with improved half-life
granted -
US 9127057
Anti-IL-23 heterodimer specific antibodies
granted -
US 8932588
Treatment of cancer involving mutated KRAS or BRAF genes
granted -
US 8901279
Humanized antibodies with anti-tumor activity
granted